Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7654)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 28, 2021 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yin GQ, Li J, Zhong B, Yang YF, Wang MR. New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage. World J Gastroenterol 2021; 27(8): 666-676 [PMID: 33716446 DOI: 10.3748/wjg.v27.i8.666] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i8/666.htm |
| Number | Citing Articles |
| 1 |
Xinhui Wang, Xiaoli Liu, Peng Wang, Lihua Yu, Fengna Yan, Huiwen Yan, Dongdong Zhou, Zhiyun Yang. Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia. Journal of Hepatocellular Carcinoma 2021; : 1253 doi: 10.2147/JHC.S330301
|
| 2 |
Guo-Qing Yin, Ke-Ping Chen, Xiao-Chun Gu. Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment. World Journal of Gastroenterology 2022; 28(40): 5784-5800 doi: 10.3748/wjg.v28.i40.5784
|
| 3 |
Xu Cao, Hening Chen, Zhiguo Li, Xiaoke Li, Xianzhao Yang, Qiushuo Jin, Yijun Liang, Jiaxin Zhang, Meiyue Zhou, Ningyi Zhang, Guang Chen, Hongbo Du, Xiaobin Zao, Yong’an Ye. Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.985084
|
| 4 |
Ankita Singh, Jitendra Kumar, Jyoti Verma, Naidu Subbarao, Shivani Sapra, Ashok Kumar Prasad, Vijay Kumar, Deepti Sharma. Synthesis of IR‐415 Derivatives and Evaluation of their Antiviral Activity Against Hepatitis B Virus. ChemistrySelect 2023; 8(29) doi: 10.1002/slct.202300701
|
| 5 |
祥运 张. Research Progress of Low-Level Viraemia in Patients with Chronic Hepatitis B. Advances in Clinical Medicine 2023; 13(12): 20083 doi: 10.12677/ACM.2023.13122827
|
| 6 |
Deborah Palazzotti, Martina Sguilla, Giuseppe Manfroni, Violetta Cecchetti, Andrea Astolfi, Maria Letizia Barreca. Small Molecule Drugs Targeting Viral Polymerases. Pharmaceuticals 2024; 17(5): 661 doi: 10.3390/ph17050661
|
| 7 |
Yibo Liu, Wenfang Guo, Minhui Li. Diammonium Glycyrrhizinate Preparation for Liver Function Recovery in Chronic
Hepatitis B in China: A Meta-analysis with Trial Sequential Analysis. Current Pharmaceutical Design 2022; 28(25): 2089 doi: 10.2174/1381612828666220421134910
|
| 8 |
Zhong-Bin Li, Dan-Dan Chen, Yun-Fei Jia, Qing-Juan He, Li Cui, Feng-Xia Du, Yao-Jie Kang, Xin Feng, Mengwen He, Xue-Yuan Jin, Jing Chen, Yudong Wang, Dong Ji, George Lau, Shu-Gao Wu. Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatment. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1413589
|